![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, July 11, 2021 11:18:30 AM
With 350 mg of leronlimab , efficacy of 81% , and not one serious side effect.
Next 2 drugs approved for these group of patients ,
are..
--Maraviroc with 45% efficacy , and very serious side effects , Black Box warning attached to it..
--Ibalizumab , IV infusion every 2 weeks , and 43% efficacy.
When our combo study finished February 2018 ,
Gilead was doing at this time phase 1 study for their capcid inhibitor , this drug also SC injection given every few months is for the same group of HIV patients as Leronlimab is in combo ..
So FDA worked VERY hard to delay our approval for 3 1/2 years now , until Gilead is ready.
Couple of weeks ago , I read that Gilead just applied for approval for their capcid inhibitor.
Congratulation FDA, Dr Fauci , you did it !!!!!!!!
And with COVID , having good results in over 90 critical patients ,
and in CD12 , group B , critical , over 60 patients ,
with injection at 0 and 7 days , improved mortality benefit above SOC..
is , at ..
--.7 days ,78%
--14 days ,82%
--21 days ,50%
--28 days ,31%
We could see here how beautiful leronlimab is helping these patients to survive , and doctors were right , 2 more doses needed.
And looking at these EIND patients and CD12 group "B" , FDA not giving us EUA in this pandemic , with advise to use 4 doses , is a
CRIMINAL ACT ,
and I hope one day families of people who are dying all the time will go after FDA.
Or someone will , this should not be just left like that.
First FDA sabotage our study , not allowing to have 4 weeks injections . NO , not one even reason for it if doctors asking for 4 weeks ..
Patients using leronlimab for close to 7 years weekly in HIV , without one serious problem ....this was plain , only a sabotage of this study , regardless how many more people will die...
So this is where we are , without all FDA and Fauci being in jail for all this , I don't see any approval for us in USA.
Thank goodness there are other countries , and if our Brazil study will be as good as we think , they will give us EUA and then approval in many other places .
Lets just start this study asap.
GLTA longs ..
And ALL as always IMO.
Recent CYDY News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 09:15:10 PM
- Form SC TO-I - Tender offer statement by Issuer • Edgar (US Regulatory) • 06/03/2024 09:10:56 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:17:30 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:16:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:09:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:20 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:16:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/22/2024 10:16:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/22/2024 05:15:08 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:00:24 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:31:57 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/29/2024 10:22:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:40:14 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 10:15:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 10:16:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:30 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM